Virchow and his triad: a question of attribution

@article{Bagot2008VirchowAH,
  title={Virchow and his triad: a question of attribution},
  author={Catherine N Bagot and Roopen Arya},
  journal={British Journal of Haematology},
  year={2008},
  volume={143}
}
  • C. Bagot, R. Arya
  • Published 1 October 2008
  • Medicine
  • British Journal of Haematology
Virchow’s triad describes three factors that contribute to the development of venous thrombosis: hypercoagulability, stasis and endothelial injury. Yet, extensive review of the historical literature casts doubt on the existence of a triad described by Virchow in the form it is currently quoted throughout contemporary medical literature. Certainly his work involved extensive study of venous thrombosis and pulmonary embolism, with these two terms being coined by Virchow, but a triad of factors… Expand
Virchow’s Contribution to the Understanding of Thrombosis and Cellular Biology
TLDR
For much of the later half of the twentieth century, the so-called Virchow’s Triad has formed the basis for understanding the pathogenesis of VTE and is still widely used to assess VTE risk. Expand
Is ‘Virchow’s triad’ useful? – response to Malone and Agutter
TLDR
The components of the triad provide an excellent resource in clinical practice for recalling the risk factors for venous thrombosis and, in turn, improving patients’ outcomes by administering preventative measures when appropriate. Expand
Procoagulant Activity in Hemostasis and Thrombosis: Virchow's Triad Revisited
TLDR
It is suggested that cross-talk among the 3 components of Virchow's triad is necessary for hemostasis and determines propensity for thrombosis or bleeding, and coagulopathies are complex, multifactorial, and interactive. Expand
Virchow’s triad
  • B. Dickson
  • Medicine
  • British journal of haematology
  • 2009
TLDR
It is perhaps most accurate to suggest that the triad was misattributed to Virchow, rather than misinterpreted by the authors' predecessors. Expand
Deep venous thrombosis: The valve cusp hypoxia thesis and its incompatibility with modern orthodoxy.
TLDR
This paper identifies and discusses seven ways in which the VCHT is incompatible with these mainstream beliefs about the aetiology of venous thrombosis, and indicates new approaches to mechanical prophylaxis against DVT. Expand
Markers of thrombosis in patient with thrombophilia
TLDR
These results are very important in predicting the recurrence ofThrombotic events so as to take the prophylactic and therapeutic measures needed in patients with thrombophilia. Expand
Venous Thromboembolism: Genetics and Thrombophilias.
TLDR
The current validated hereditary thrombophilias including their history, prevalence, and association with VTE are described to explore the controversies of why, who, and when to test as well as discuss contemporary societal guidelines. Expand
Thrombosis in vasculitis.
  • A. Gaffo
  • Medicine
  • Best practice & research. Clinical rheumatology
  • 2013
TLDR
An association between venous thrombo-embolic disease and vasculitides associated with anti-neutrophil cytoplasmic antibodies (ANCAs) is confirmed and an increased cardiovascular risk is now also recognised for vasculites associated with ANCAs. Expand
Use of Viscoelastography in Malignancy-Associated Coagulopathy and Thrombosis: A Review.
TLDR
Early results demonstrate the utility of both TEG and ROTEM in the prediction of hypercoagulable states and thromboembolic complications in oncologic patients. Expand
The sticky platelet syndrome. Important markers of thrombosis in patient with thrombophilia
TLDR
The sticky platelet syndrome type I was the most frequent in this study, followed by type III and type II, and there were significant differences between the presence of biomarkers and development of thrombotic disease. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 71 REFERENCES
Venous Thrombosis: On the History of Virchow's Triad
TLDR
A comprehensive review of both the English and French literature suggests that the ideas presented in the triad were neither original to Virchow, nor did he appear to synthesize them in the manner in which they are currently held. Expand
The aetiology of deep venous thrombosis.
TLDR
This literature provides the basis for an alternative hypothesis of DVT aetiology, published some 30 years ago, which has been experimentally corroborated and is compatible with recent cell and molecular biological studies of the venous endothelium. Expand
New considerations in the diagnosis and therapy of deep vein thrombosis.
TLDR
There is growing evidence that early lysis is more likely to preserve valve function leading to a decrease in the incidence of postthrombotic syndrome, which is a known long-term complication of DVT and IFDVT. Expand
Virchow’s Triad Revisited: Blood Constituents
  • I. Chung, G. Lip
  • Medicine
  • Pathophysiology of Haemostasis and Thrombosis
  • 2003
TLDR
It is suggested that the patients with the highest levels of the markers appear to be the highest risk of disease progression, and if so, a panel of 'high risk' blood constituent indices (platelet and coagulation markers) may potentially give a composite score of risk, and may be a useful tool in predicting subjects at highest risk. Expand
Rudolf Ludwig Karl Virchow: pathologist, physician, anthropologist, and politician. Implications of his work for the understanding of cerebrovascular pathology and stroke.
TLDR
The contributions of Rudolf Virchow to the current understanding of cerebrovascular pathology are reviewed, including his descriptions of the phenomena he called "embolism" and "thrombosis" as well as the origins of ischemia, changed the understanding of stroke. Expand
Venous Thrombosis: An Overview
TLDR
Clinically and economically, venous thrombosis is best managed by prevention, and laboratory and clinical data have refined knowledge of how these factors interact to result in clinically significant disease. Expand
Venous thrombosis: the history of knowledge
  • P. Mannucci
  • Medicine
  • Pathophysiology of Haemostasis and Thrombosis
  • 2002
TLDR
The first well documented case of venous thrombosis is depicted in a beautifully illustrated manuscript written in the 13th century and currently preserved in Paris at the Bibliothèque Nationale (MS Fr 2829, Folio 87). Expand
Venous thrombosis. An account of the first documented case.
TLDR
The search includes not only the writings of Hippocrates, Erasistratus, Galen, Coelius Aurelianus, Ibn-an-Nafiz, and Avicenna but also art including bas-reliefs, statuary, carvings, paintings, figurines, jewelry, pottery, engravings and coins from ancient Egypt, Greece, Rome, Persia, Arabic countries, and South America. Expand
Femoral vein thrombosis and total hip replacement.
TLDR
It is my clinical impression that DVT is rare in rheumatoid disease and aspirin is well known to influence the clotting mechanism, and it is important that that information should be made available. Expand
Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.
TLDR
A previously unrecognized mechanism for familial thromboembolic disease is described that is characterized by poor anticoagulant response to activated protein C (APC), and as two additional, unrelated cases with thrombosis and inherited poor antICOagulants response to APC are identified, this may constitute an important cause for familialThrombophilia. Expand
...
1
2
3
4
5
...